Arman Qamar: We are Routinely Evaluating VTE PRS in the Clinic in Many of Our Patients With Unprovoked VTE
Arman Qamar, Interventional Cardiologist NorthShore University HealthSystem, shared a post on LinkedIn:
“We are routinely evaluating VTE PRS in the clinic in many of our patients with unprovoked VTE. We discuss the evolving science in our recent review.”
Quoting RPTH Journal post:
“Recent studies demonstrate that polygenic risk score (PRS) significantly improves VTE risk prediction beyond traditional clinical factors. Recent findings indicate that PRS could inform thromboprophylaxis decisions for high-risk patients.”
Title: Role of polygenic risk scores in venous thromboembolism: current state and future directions
Authors: Aman Goyal, Sonia Hurjkaliani, Kevin Michael Alexander, Jianfeng Xu, Manan Pareek, Arman Qamar
Read full article here.
Stay updated with Hemostasis Today.
-
Jul 22, 2026, 20:51Anu Thomas: ET vs IUT – Two Life-Saving Procedures, Different Stages of Care
-
Jul 22, 2026, 20:50Javed Anees: When and Whether to Restart a DOAC after Spontaneous ICH
-
Jul 22, 2026, 20:49Gerard J. Myers: Why Do Clinicians Ignore The Potential Morbidity Associated With IV Air and The Effects of VAE?
-
Jul 22, 2026, 20:47Phillip Smith: The Woman Who Was Told She Couldn’t Have Hemophilia
-
Jul 22, 2026, 20:45David McIntosh: Artificial Blood Will Require More Blood Donation, Not Less
-
Jul 22, 2026, 20:04Maria Cherska: Why Female Vascular Biology Matters for Precision Cardiometabolic Medicine
-
Jul 22, 2026, 19:27Alexandra Yakusheva: Stepping Into Senior Authorship – Our New Paper is Out!
-
Jul 22, 2026, 18:31Clivaz Léa: Presenting Research on Pregnancy-Related Pulmonary Embolism at ISTH 2026
-
Jul 22, 2026, 18:18Mohammed Alo: Arteries And Veins Are Structurally Built For Different Jobs